New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
AEON Biopharma, Inc. (AEON) vs BioCardia, Inc. (BCDA)
- AEON Biopharma, Inc. AEON 0.12 −7.69%
- BioCardia, Inc. BCDA 0.79 +2.60%
AEON Biopharma, Inc. and BioCardia, Inc. are both Biotechnology companies. AEON Biopharma, Inc. and BioCardia, Inc. are of similar size ($11.7M and $11.2M). Across the 9 metrics below, BioCardia, Inc. leads on 5 and AEON Biopharma, Inc. on 4.
Valuation
Profitability
| Metric | AEON | BCDA | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 70.18% |
| Operating margin | — | (2,010.75%) | 0.00% |
| Net margin | — | (1,999.77%) | 0.00% |
| Free cash flow margin | — | — | 0.00% |
| Return on equity | 544.66% | (443.27%) | (51.58%) |
| Return on assets | (416.57%) | (166.46%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack